Researcher profile · Semantic Scholar

I. Tartakovsky

h-index: 10
Works: 26
Citations: 514

Most-cited papers

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
J. Halton, L. Brandão, M. Luciani, L. Bomgaars +82 more
2020The Lancet Haematology124 citations
Semantic Scholar
Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial.
O. Napryeyenko, G. Sonnik, I. Tartakovsky
2009Journal of Neurological Sciences90 citations
Semantic Scholar
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
L. Brandão, M. Albisetti, J. Halton, L. Bomgaars +14 more
2019Blood85 citations Open access
Semantic Scholar
Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program
J. Fanikos, D. Murwin, F. Gruenenfelder, I. Tartakovsky +6 more
2019Thrombosis and Haemostasis44 citations Open access
Semantic Scholar
Antimicrobial Resistance of Listeria monocytogenes Strains Isolated from Humans, Animals, and Food Products in Russia in 1950–1980, 2000–2005, and 2018–2021
P. Andriyanov, P. Zhurilov, E. Liskova, T. Karpova +9 more
2021Antibiotics35 citations Open access
Semantic Scholar
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism
J. Halton, A. Picard, R. Harper, F. Huang +9 more
2017Thrombosis and Haemostasis29 citations Open access
Semantic Scholar
Anticoagulant Effects of Dabigatran in Paediatric Patients Compared with Adults: Combined Data from Three Paediatric Clinical Trials
H. Maas, S. Gropper, F. Huang, J. Stangier +4 more
2018Thrombosis and Haemostasis18 citations Open access
Semantic Scholar
Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism
Daniel Röshammar, F. Huang, M. Albisetti, L. Bomgaars +11 more
2021Journal of Thrombosis and Haemostasis14 citations Open access
Semantic Scholar
Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism
M. Albisetti, A. Schlosser, M. Brueckmann, S. Gropper +4 more
2017Research and Practice in Thrombosis and Haemostasis12 citations Open access
Semantic Scholar
Design and rationale for the DIVERSITY study: An open‐label, randomized study of dabigatran etexilate for pediatric venous thromboembolism
M. Albisetti, B. Biss, L. Bomgaars, L. Brandão +11 more
2018Research and Practice in Thrombosis and Haemostasis11 citations Open access
Semantic Scholar
Dabigatran Etexilate for the Treatment of Acute Venous Thromboembolism in Children: Results of an Open-Label, Phase 2b/3, Randomised Clinical Trial
J. Halton, L. Brandão, M. Luciani, L. Bomgaars +16 more
202010 citations
Semantic Scholar
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia
L. Brandão, I. Tartakovsky, M. Albisetti, J. Halton +9 more
2022Blood Advances8 citations Open access
Semantic Scholar
Phase 3, single‐arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design
M. Luciani, M. Albisetti, B. Biss, L. Bomgaars +11 more
2018Research and Practice in Thrombosis and Haemostasis7 citations Open access
Semantic Scholar
Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials
L. Mitchell, Daniel Röshammar, F. Huang, M. Albisetti +9 more
2022Thrombosis and Haemostasis5 citations Open access
Semantic Scholar
Analyses of a randomised controlled trial
O. Napryeyenko, G. Sonnik, I. Tartakovsky
20095 citations
Semantic Scholar
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease
M. Albisetti, I. Tartakovsky, J. Halton, L. Bomgaars +8 more
2024Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease4 citations Open access
Semantic Scholar
Pharmacokinetics (PK) and Pharmacodynamics (PD), Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Etexilate Given after Standard Anticoagulant Therapy in Children from Birth to Less Than One Year Old, with Venous Thromboembolism
J. Halton, A. Picard, R. Harper, F. Huang +8 more
20164 citations
Semantic Scholar
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Given after Standard Anticoagulant Therapy in Children (Two Age Groups: 1-<2 and 2-<12 Years Old), with Venous Thromboembolism
J. Halton, M. Albisetti, M. Luciani, F. Huang +6 more
20164 citations
Semantic Scholar
Outcomes of the multicenter monitoring of the causative agent of invasive listeriosis in the metropolis
O. Voronina, N. Ryzhova, M. Kunda, E. Aksenova +7 more
2023Journal of microbiology, epidemiology and immunobiology3 citations Open access
Semantic Scholar
Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia
L. Brandão, I. Tartakovsky, M. Albisetti, L. Bomgaars +11 more
20202 citations Open access
Semantic Scholar
Listeria monocytogenes today
O. Gruzdeva, I. Tartakovsky, V. V. Maleev, R. Saitgareev +4 more
2022Medical Journal of the Russian Federation1 citations
Semantic Scholar
Abstract 9192: Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children With Congenital Heart Disease
M. Albisetti, I. Tartakovsky, J. Halton, L. Bomgaars +8 more
2021Circulation0 citations
Semantic Scholar
Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial
J. Halton, L. Brandão, M. Luciani, L. Bomgaars +14 more
20200 citations Open access
Semantic Scholar
Rationale and Design of a Phase IIb/III Open-Label, Multicenter Study of Dabigatran Etexilate for Venous Thromboembolism in Children: The Diversity Study
M. Albisetti, Ivan Manastirski, M. Brueckmann, S. Gropper +7 more
20160 citations
Semantic Scholar
Rationale and Design of a Phase III Single-Arm Multicenter Study of Dabigatran Etexilate for the Secondary Prevention of Venous Thromboembolism in Children
M. Luciani, M. Albisetti, Ivan Manastirski, M. Brueckmann +8 more
20160 citations
Semantic Scholar
Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for the Treatment and Secondary Prevention of Venous Thromboembolism
M. Albisetti, A. Schlosser, M. Brueckmann, S. Gropper +4 more
20160 citations
Semantic Scholar

L. Mitchell

×16

S. Gropper×16

F. Huang×14

M. Luciani×12

E. Chalmers×11

L. Bomgaars×10

I. Nurmeev×8

Monika Simetzberger×6